We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Univar (UNVR) Buys Kale Kimya, Expands Product Portfolios
Read MoreHide Full Article
Univar Solutions Inc. acquired Kale Kimya, a Turkey-based specialty chemicals distributor. Terms of the deal have been kept under wraps.
This acquisition will help Univar to expand its Beauty and Personal Care, Home and Industrial Cleaning portfolios. Through the top-notch formulation laboratory capabilities and technical expertise of Kale Kimya, Univar can offer extensive products like surfactants, actives, emulsifiers, preservatives, UV filters, fragrances, polymers, conditioners, esters and emollients in the market.
The company expects its Ingredients and Specialty business to grow further and boost its geographic footprint through this acquisition. It anticipates that investment in Kale Kimya will help the company capitalize on changing consumer trends in the market. UNVR also expects to serve its consumer efficiently in the region through experience and knowledge of Kale Kimya.
Both Univar and Kale Kimya share market-leading reputations, expert technical support, a spirit of innovation and relentless dedication, which are expected to aid the two companies in providing exceptional customer service.
UNVR’s shares have gained 21.1% in the past year, outperforming industry’s growth of 4.1%.
Image Source: Zacks Investment Research
Univar, in its fourth-quarter call, said that it expects strong operational execution, market share gains and savings from cost management. The company expects its adjusted EBITDA for the fourth quarter of 2022 to be between $180 million and $200 million. For full-year 2022, UNVR expects its adjusted EBITDA to be in the range of $1,050 million to $1,080 million compared with $1,040-$1,080 million expected earlier.
Nucor’s shares have gained 65.5% in the past year. The company has a projected earnings growth rate of 21.5% for the current year. NUE beat the Zacks Consensus Estimate in all of the last four quarters. It delivered a trailing four-quarter earnings surprise of 28.4% on average.
Commercial Metals’ shares have gained 54.8% in the past year. The Zacks Consensus Estimate for CMC’s current fiscal-year earnings has been revised 9.9% upward in the past 60 days. Commercial Metals beat the Zacks Consensus Estimate in all of the last four quarters.It delivered a trailing four-quarter earnings surprise of 16.7% on average.
Cal-Maine’s shares have gained 37.3% in the past year. The Zacks Consensus Estimate for CALM’s earnings for the current fiscal has been revised 73.8% upward in the past 60 days. The company has a projected earnings growth rate of 417.7% for the current fiscal year.
Cal-Maine topped Zacks Consensus Estimate in three of the last fourth quarters while missing once. It delivered a trailing four-quarter earnings surprise of 15.3% on average.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Univar (UNVR) Buys Kale Kimya, Expands Product Portfolios
Univar Solutions Inc. acquired Kale Kimya, a Turkey-based specialty chemicals distributor. Terms of the deal have been kept under wraps.
This acquisition will help Univar to expand its Beauty and Personal Care, Home and Industrial Cleaning portfolios. Through the top-notch formulation laboratory capabilities and technical expertise of Kale Kimya, Univar can offer extensive products like surfactants, actives, emulsifiers, preservatives, UV filters, fragrances, polymers, conditioners, esters and emollients in the market.
The company expects its Ingredients and Specialty business to grow further and boost its geographic footprint through this acquisition. It anticipates that investment in Kale Kimya will help the company capitalize on changing consumer trends in the market. UNVR also expects to serve its consumer efficiently in the region through experience and knowledge of Kale Kimya.
Both Univar and Kale Kimya share market-leading reputations, expert technical support, a spirit of innovation and relentless dedication, which are expected to aid the two companies in providing exceptional customer service.
UNVR’s shares have gained 21.1% in the past year, outperforming industry’s growth of 4.1%.
Image Source: Zacks Investment Research
Univar, in its fourth-quarter call, said that it expects strong operational execution, market share gains and savings from cost management. The company expects its adjusted EBITDA for the fourth quarter of 2022 to be between $180 million and $200 million. For full-year 2022, UNVR expects its adjusted EBITDA to be in the range of $1,050 million to $1,080 million compared with $1,040-$1,080 million expected earlier.
Univar Solutions Inc. Price and Consensus
Univar Solutions Inc. price-consensus-chart | Univar Solutions Inc. Quote
Zacks Rank & Key Picks
Univar currently carries a Zacks Rank #4 (Sell).
Better-ranked stocks to consider in the basic materials space include Nucor Corporation (NUE - Free Report) , Commercial Metals Company (CMC - Free Report) and Cal-Maine Foods, Inc. (CALM - Free Report) . All three stocks have a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Nucor’s shares have gained 65.5% in the past year. The company has a projected earnings growth rate of 21.5% for the current year. NUE beat the Zacks Consensus Estimate in all of the last four quarters. It delivered a trailing four-quarter earnings surprise of 28.4% on average.
Commercial Metals’ shares have gained 54.8% in the past year. The Zacks Consensus Estimate for CMC’s current fiscal-year earnings has been revised 9.9% upward in the past 60 days. Commercial Metals beat the Zacks Consensus Estimate in all of the last four quarters.It delivered a trailing four-quarter earnings surprise of 16.7% on average.
Cal-Maine’s shares have gained 37.3% in the past year. The Zacks Consensus Estimate for CALM’s earnings for the current fiscal has been revised 73.8% upward in the past 60 days. The company has a projected earnings growth rate of 417.7% for the current fiscal year.
Cal-Maine topped Zacks Consensus Estimate in three of the last fourth quarters while missing once. It delivered a trailing four-quarter earnings surprise of 15.3% on average.